"adalimumab" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "ada-",
        "3": "-lim-",
        "4": "-umab",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "immunomodulating",
        "t3": "human monoclonal antibody"
      },
      "expansion": "ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "adalimumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English entries with language name categories using raw markup",
          "parents": [
            "Entries with language name categories using raw markup",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -lim-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -umab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor."
      ],
      "id": "en-adalimumab-en-noun-OF7OJx1d",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "immunosuppressive",
          "immunosuppressive"
        ],
        [
          "genetically engineered",
          "genetically engineered"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "subcutaneous",
          "subcutaneous"
        ],
        [
          "injection",
          "injection"
        ],
        [
          "autoimmune",
          "autoimmune"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "Crohn's disease",
          "Crohn's disease"
        ],
        [
          "psoriasis",
          "psoriasis"
        ],
        [
          "tumor necrosis factor",
          "tumor necrosis factor"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "translations": [
        {
          "code": "fi",
          "lang": "Finnish",
          "sense": "monoclonal antibody",
          "word": "adalimumabi"
        }
      ],
      "wikipedia": [
        "adalimumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌeɪ.dəˈlɪm.jəˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "adalimumab"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "ada-",
        "3": "-lim-",
        "4": "-umab",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "immunomodulating",
        "t3": "human monoclonal antibody"
      },
      "expansion": "ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "adalimumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 5-syllable words",
        "English entries with incorrect language header",
        "English entries with language name categories using raw markup",
        "English lemmas",
        "English nouns",
        "English terms interfixed with -lim-",
        "English terms suffixed with -umab",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "immunosuppressive",
          "immunosuppressive"
        ],
        [
          "genetically engineered",
          "genetically engineered"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "subcutaneous",
          "subcutaneous"
        ],
        [
          "injection",
          "injection"
        ],
        [
          "autoimmune",
          "autoimmune"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "Crohn's disease",
          "Crohn's disease"
        ],
        [
          "psoriasis",
          "psoriasis"
        ],
        [
          "tumor necrosis factor",
          "tumor necrosis factor"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "adalimumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌeɪ.dəˈlɪm.jəˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "translations": [
    {
      "code": "fi",
      "lang": "Finnish",
      "sense": "monoclonal antibody",
      "word": "adalimumabi"
    }
  ],
  "word": "adalimumab"
}